XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   88,054,127      
Beginning balance at Dec. 31, 2022 $ 256,857 $ 88 $ 970,535 $ (337) $ (713,429)
Increase (Decrease) in Stockholders' Equity          
Share-based compensation 4,363   4,363    
Employee stock purchase plan purchases (in shares)   308,000      
Employee stock purchase plan purchases 357 $ 1 356    
RSU stock issuance (in shares)   221,440      
Comprehensive loss:          
Unrealized (loss) gain on debt investments, net 106     106  
Net loss (21,372)       (21,372)
Comprehensive loss (21,266)        
Ending balance (in shares) at Mar. 31, 2023   88,583,567      
Ending balance at Mar. 31, 2023 $ 240,311 $ 89 975,254 (231) (734,801)
Beginning balance (in shares) at Dec. 31, 2023 88,929,300 88,929,300      
Beginning balance at Dec. 31, 2023 $ 193,029 $ 89 988,457 7 (795,524)
Increase (Decrease) in Stockholders' Equity          
Share-based compensation 2,749   2,749    
Employee stock purchase plan purchases (in shares)   419,546      
Employee stock purchase plan purchases 378 $ 1 377    
RSU stock issuance (in shares)   281,056      
Comprehensive loss:          
Unrealized (loss) gain on debt investments, net (185)     (185)  
Net loss (21,869)       (21,869)
Comprehensive loss $ (22,054)        
Ending balance (in shares) at Mar. 31, 2024 89,629,902 89,629,902      
Ending balance at Mar. 31, 2024 $ 174,102 $ 90 $ 991,583 $ (178) $ (817,393)